Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kinesin family member 16B (KIF16B) is a plus end-directed microtubule-dependent motor protein of the kinesin-3 family that primarily mediates the *anterograde* transport of early endosomes along microtubules[1][2]. KIF16B contains a PX (phox homology) domain that binds strongly to phosphatidylinositol-3-phosphate (PtdIns(3)P) on endosomal membranes, facilitating endosome tethering and motility[3][5]. Through this mechanism, KIF16B regulates endosome positioning and the balance between *receptor recycling* and *degradation* (notably EGFR and FGFR), impacting signal transduction, membrane trafficking, and cellular polarization in various systems including epithelial cells and neurons[1][2][4]. Disruption of KIF16B leads to mislocalization and aggregation of endosomes, causing defects in receptor trafficking and neuronal function. The protein has been mechanistically linked to processes relevant for development and disease, but is not currently a known drug target, and no direct drug interactions, mechanistic inhibitors, or established safety concerns have been reported in the literature to date[2][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kinesin family member 16B (KIF16B).